LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2660 | 5667 | 0.4693 | 0.2970 |
MCF7 | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5117 | 5667 | 0.9028 | 0.8713 |
MCF7 | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1861 | 5667 | 0.3284 | 0.1104 |
MCF7 | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1013 | 5667 | 0.1788 | -0.0878 |
MCF7 | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2633 | 5667 | 0.4646 | 0.2907 |
MCF7 | PD0325901 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 2392 | 5667 | 0.4221 | 0.2345 |
MCF7 | PD0325901 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2287 | 5667 | 0.4036 | 0.2099 |
MCF7 | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 6034 | 5667 | 1.0647 | 1.0857 |
MCF7 | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3553 | 5667 | 0.6269 | 0.5057 |
MCF7 | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3172 | 5667 | 0.5597 | 0.4168 |
MCF7 | PF431396 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1405 | 5667 | 0.2479 | 0.0037 |
MCF7 | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 2002 | 5667 | 0.3532 | 0.1433 |
MCF7 | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1233 | 5667 | 0.2177 | -0.0363 |
MCF7 | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5626 | 5667 | 0.9926 | 0.9902 |
MCF7 | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1357 | 5667 | 0.2394 | -0.0075 |
MCF7 | PI103 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1282 | 5667 | 0.2262 | -0.0249 |
MCF7 | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5426 | 5667 | 0.9573 | 0.9435 |
MCF7 | QL-X-138 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2037 | 5667 | 0.3595 | 0.1515 |
MCF7 | QL-XII-47 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1122 | 5667 | 0.1981 | -0.0623 |
MCF7 | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1703 | 5667 | 0.3006 | 0.0735 |
MCF7 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1609 | 5667 | 0.2839 | 0.0515 |
MCF7 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 4844 | 5667 | 0.8546 | 0.8075 |
MCF7 | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 6160 | 5667 | 1.0869 | 1.1151 |
MCF7 | XL147 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 6369 | 5667 | 1.1237 | 1.1639 |
MCF7 | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1515 | 5667 | 0.2673 | 0.0294 |